Show simple item record

NSAIDs for high-risk patients: none, celecoxib, or naproxen?

dc.contributor.authorMcGettigan, Pen_US
dc.contributor.authorOlsen, A-MSen_US
dc.date.accessioned2020-10-22T15:38:26Z
dc.date.available2017-04-06en_US
dc.date.issued2017-06-17en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/67717
dc.format.extent2351 - 2352en_US
dc.languageengen_US
dc.relation.ispartofLanceten_US
dc.subjectAnti-Inflammatory Agents, Non-Steroidalen_US
dc.subjectCelecoxiben_US
dc.subjectCyclooxygenase 2 Inhibitorsen_US
dc.subjectHumansen_US
dc.subjectIbuprofenen_US
dc.subjectNaproxenen_US
dc.subjectPyrazolesen_US
dc.subjectSulfonamidesen_US
dc.titleNSAIDs for high-risk patients: none, celecoxib, or naproxen?en_US
dc.typeArticle
dc.identifier.doi10.1016/S0140-6736(17)30980-7en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/28410794en_US
pubs.issue10087en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume389en_US
dcterms.dateAccepted2017-04-06en_US


Files in this item

Thumbnail
Name:
Lancet NSAIDs NoneCeleNaprox McG ...
Size:
158.2Kb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record